Biomarker research refers to the study and identification of specific molecules or characteristics in our body that can indicate the presence, progression, or risk of a disease or a specific condition. These biomarkers help doctors and researchers better understand and diagnose illnesses, monitor treatment effectiveness, and develop new therapies.
Full definition
Our research agenda includes
advancing biomarker research, understanding why those under 50 are increasingly diagnosed with colon cancer, decreasing late - state diagnosis of high - risk populations, closing the referral gap for screening and diagnostic testing, and advancing long - term survivorship psychosocial concerns.
This webinar will present the latest advances that are allowing researchers to move
miRNA biomarker research from discovery in the lab to application in the clinic.
He is already supervising the EU -
funded biomarker research consortium «Elucidating Pathways of Steatohepatitis» (EPoS), in which both researchers are participating.
Sudhir Srivastava, chief of the
Cancer Biomarkers Research Group at the National Cancer Institute in Bethesda, Maryland, says that the prostate cancer genome could lead to a «companion diagnosis» test for the PSA test and spur the search for new drug targets.
Our research agenda includes
advancing biomarker research, understanding why those under 50 are increasingly diagnosed with colon cancer, decreasing late - state diagnosis of high - risk populations, closing the referral gap for screening and diagnostic testing, and advancing long - term survivorship psychosocial concerns.
«We extended
this biomarker research to the domain of professional sports to test its merit as an objective and rapid way to determine players» severity of brain injury,» says lead author, Robert Siman, PhD, Research Professor of Neurosurgery at Penn. «This blood test may aid neurobiologically - informed decisions on suitability for return to play following a sports - related concussion.»
The Core Immunology Laboratory at Blood Systems Research Institute has focused on performing high - throughput immune assays including cell phenotyping and sorting at our flow cytometry facility and soluble markers at
our biomarker research facility.
Our research agenda includes advancing
biomarker research, understanding why those under 50 are increasingly diagnosed with colon cancer, decreasing late - state diagnosis of high - risk populations, closing the referral gap for screening and diagnostic testing, and advancing long - term survivorship psychosocial concerns.
Our research agenda includes advancing
biomarker research, understanding why those under 50 are increasingly diagnosed with colon cancer, decreasing late - state diagnosis of high - risk populations, closing the referral gap for screening and diagnostic testing, and advancing long - term survivorship psychosocial concerns.
Our research agenda includes advancing
biomarker research, understanding why those under 50 are increasingly diagnosed with colon cancer, decreasing late - state diagnosis of high - risk populations, closing the referral gap for screening and diagnostic testing, and advancing long - term survivorship psychosocial concerns.